Evidence map›Paper›PMID 35669279›Full record

ArticleInternational journal of peptide research and therapeutics2022

B-Cell Epitope Mapping from Eight Antigens of

Farzaneh Vahedi, Younes Ghasemi, Amir Atapour, Kamiar Zomorodian, Maryam Ranjbar, Ahmad Monabati, Navid Nezafat, Amir Savardashtaki

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of peptide research and therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Farzaneh VahediDepartment of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
Younes GhasemiPharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Amir AtapourDepartment of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
Kamiar ZomorodianDepartment of Parasitology & Mycology, School of Medicines, Shiraz University of Medical Sciences, Shiraz, Iran.
Maryam RanjbarDepartment of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
Ahmad MonabatiDepartment of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran.
Navid NezafatPharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID 0000-0001-8103-2685
Amir SavardashtakiDepartment of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
Shiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive candidiasis is an emerging fungal infection and a leading cause of morbidity in health care facilities. Despite advances in antifungal therapy, increased antifungal drug resistance in Supplementary Information: The online version contains supplementary material available at 10.1007/s10989-022-10413-1.

Indexed as

AntigensB-cell epitopeCandida albicansDiagnostic kitEpitope mapping

Identifiers

PMID35669279
PMCPMC9136830
OpenAlexW4281763406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.